Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trialPeter Mitchell, Justin Whitley, Bernard Yan et al.|The Lancet|2022Cited by 225
Antibacterial Cascade Catalytic Glutathione-Depleting MOF NanoreactorsXi Zhou, Xingcai Zhang, M. Wang et al.|ACS Applied Materials & Interfaces|2022Cited by 97